Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmacological Reports

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1734-1140(11)70697-1PMID 22358081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Schizophrenia and major depression as inflammatory CNS disorders

  2012cited by this paper
• Biochemical and structural characterization of mouse mitochondrial aspartate aminotransferase, a newly identified kynurenine aminotransferase-IV.

  2011cited by this paper
• The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.

  2011cited by this paper
• Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.

  2010cited by this paper
• Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases

  2010cited by this paper
• Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.

  2010cited by this paper
• Pharmacological Manipulation of Kynurenic Acid

  2009cited by this paper
• The Astrocyte-Derived α7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex

  2009cited by this paper
• New data on the ultrastructure of the corpus amylaceum (polyglucosan body)

  2009cited by this paper
• Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies

  2009cited by this paper
• Heat shock protein 60 in corpora amylacea

  2009cited by this paper
• A psychoneuroimmunological perspective to Emil Kraepelins dichotomy

  2008cited by this paper
• Biochemical and Structural Properties of Mouse Kynurenine Aminotransferase III

  2008cited by this paper
• Mitochondrial aspartate aminotransferase: a third kynurenate‐producing enzyme in the mammalian brain

  2007cited by this paper
• Kynurenines, redox disturbances and neurodegeneration in multiple sclerosis.

  2007cited by this paper
• Immunohistochemical identification of kynurenine aminotransferases in corpora amylacea in the human retina and optic nerve.

  2007cited by this paper
• Kynurenic acid synthesis in bovine retinal slices – effect of glutamate agonists

  2006cited by this paper
• Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family.

  2006cited by this paper
• Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies.

  2006cited by this paper
• Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35*

  2006cited by this paper
• A selective method for transfection of retinal ganglion cells by retrograde transfer of antisense oligonucleotides against kynurenine aminotransferase II.

  2006cited by this paper
• Corpora amylacea in glaucomatous and non-glaucomatous optic nerve and retina

  2005cited by this paper
• Expression of kynurenine aminotransferases in the rat retina during development.

  2004cited by this paper
• Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains

  2004cited by this paper
• Content of Kynurenic Acid and Activity of Kynurenine Aminotransferases in Mammalian Eyes

  2004cited by this paper
• Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-intropropionic acid toxicity in rats

  2004cited by this paper
• pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I.

  2004cited by this paper
• Age-dependent decrease of retinal kynurenate and kynurenine aminotransferases in DBA/2J mice, a model of ocular hypertension.

  2004cited by this paper
• Alterations of kynurenic acid content in the retina in response to retinal ganglion cell damage.

  2003cited by this paper
• Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

  2003cited by this paper
• Ontogenic changes of kynurenine aminotransferase I activity and its expression in the chicken retina.

  2003cited by this paper
• Expression of kynurenine aminotransferase in the subplate of the rat and its possible role in the regulation of programmed cell death.

  2002cited by this paper
• Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model.

  2002cited by this paper
• Endogenous kynurenines as targets for drug discovery and development

  2002cited by this paper
• Regulation of kynurenic acid synthesis in C6 glioma cells

  2002cited by this paper
• Changes of kynurenic acid content in the rat and chicken retina during ontogeny

  2002cited by this paper
• Drug‐induced Apoptotic Neurodegeneration in the Developing Brain

  2002cited by this paper
• Retinal ganglion cells, glaucoma and neuroprotection.

  2001cited by this paper
• The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

  2001cited by this paper
• Evidence for Intraocular Synthesis of Kynurenic Acid, a Putative Endogenous Neuroprotectant

  2001cited by this paper
• Presence of kynurenic acid and kynurenine aminotransferases in the inner retina

  2001cited by this paper
• Neonatal Asphyxia in Rats: Acute Effects on Cerebral Kynurenine Metabolism

  2001cited by this paper
• The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

  2001cited by this paper
• Immunoreactivity for Bcl‐2 and C‐Jun/AP1 in hippocampal corpora amylacea after ischaemia in humans

  2001cited by this paper
• Presynaptic kynurenate‐sensitive receptors inhibit glutamate release

  2001cited by this paper
• Control of Müller glial cell proliferation and activation following retinal injury

  2000cited by this paper
• Formation of endogenous glutamatergic receptors antagonist kynurenic acid--differences between cortical and spinal cord slices.

  2000influential reference
• Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro

  2000cited by this paper
• Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors.

  2000cited by this paper
• Distribution and developmental regulation of AMPA receptor subunit proteins in rat retina.

  2000cited by this paper
• Neuroprotective potency of kynurenic acid against excitotoxicity

  2000cited by this paper
• The distribution and developmental regulation of NMDA receptor subunit proteins in the outer and inner retina of the rat.

  2000cited by this paper
• Brain concentrations of kynurenic acid after a systemic neuroprotective dose in the gerbil model of global ischemia.

  1999cited by this paper
• Effects of in vivo sodium azide administration on the immunohistochemical localization of kynurenine aminotransferase in the rat brain.

  1999cited by this paper
• Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.

  1999cited by this paper
• Kynurenine aminotransferase I (KATI) isoform gene expression in the rat brain: an in situ hybridization study.

  1999cited by this paper
• Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder.

  1999cited by this paper
• Kynurenine metabolism in Alzheimer's disease

  1999cited by this paper
• Corpora-amylacea and the family of polyglucosan diseases.

  1999cited by this paper
• Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats

  1999cited by this paper
• Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.

  1998cited by this paper
• Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve.

  1998cited by this paper
• Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells.

  1998cited by this paper
• Characterization of rat brain kynurenine aminotransferases I and II

  1997cited by this paper
• Vitreous body glutamate concentration in dogs with glaucoma.

  1997cited by this paper
• Immuno‐localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord

  1997cited by this paper
• Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists

  1997influential reference
• Neuronal damage after the injection of aminooxyacetic acid into the rat entorhinal cortex: a silver impregnation study.

  1997cited by this paper
• Molecular basis of glutamate toxicity in retinal ganglion cells.

  1997cited by this paper
• Stereopsis and disparity vergence in monkeys with subnormal binocular vision.

  1997cited by this paper
• Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.

  1997cited by this paper
• Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes.

  1996cited by this paper
• Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging

  1996cited by this paper
• High levels of extracellular glutamate are present in retina during neonatal development

  1996cited by this paper
• Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats.

  1996cited by this paper
• Purification and Characterization of Kynurenine Aminotransferase I from Human Brain

  1994cited by this paper
• Modulation of NMDA receptor function: implications for vertebrate neural development

  1994cited by this paper
• Tau-2 immunoreactivity of corpora amylacea in the human retina and optic nerve.

  1993cited by this paper
• Contributory mechanisms in the causation of neurodegenerative disorders.

  1993cited by this paper
• Modulation of neuronal migration by NMDA receptors.

  1993cited by this paper
• Kynurenic Acid: A Potential Pathogen in Brain Disorders a

  1992cited by this paper
• Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus

  1992cited by this paper
• Immunocytochemical localization of kynurenine aminotransferase in the rat striatum: A light and electron microscopic study

  1992cited by this paper
• Developmental changes in brain kynurenic acid concentrations.

  1992cited by this paper
• Kynurenic Acid in the Quinolinate‐lesioned Rat Hippocampus: Studies In Vitro and In Vivo

  1992cited by this paper
• Neuroprotective Effects of L-Kynurenine on Hypoxia—Ischemia and NMDA Lesions in Neonatal Rats

  1992cited by this paper
• Glial changes following an excitotoxic lesion in the CNS--II. Astrocytes.

  1991cited by this paper
• Two kynurenine aminotransferases in human brain.

  1991cited by this paper
• Glial changes following an excitotoxic lesion in the CNS--I. Microglia/macrophages.

  1991cited by this paper
• Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques.

  1991cited by this paper
• Aminooxyacetic acid produces excitotoxic lesions in the rat striatum

  1991cited by this paper
• Chapter 11 Cell types using glutamate as a neurotransmitter in the vertebrate retina

  1990cited by this paper
• Purification and characterization of kynurenine-pyruvate aminotransferase from rat kidney and brain.

  1990cited by this paper
• Rat Brain Slices Produce and Liberate Kynurenic Acid upon Exposure to l‐Kynurenine

  1989cited by this paper
• Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

  1988cited by this paper
• Presence of Kynurenic Acid in the Mammalian Brain

  1988cited by this paper
• 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

  1988cited by this paper
• 7‐クロルキヌレン酸はN‐メチル‐D‐アスパラギン酸受容体複合体のグリシン調節部位での選択的きっ抗物質である

  1988cited by this paper
• The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection.

  1988cited by this paper
• Maturational changes in retinal excitatory amino acid receptors.

  1988cited by this paper

• Early-stage diabetic retinopathy: gut-metabolic triggers, immune-neurodegeneration, and interventions

  2025cites this paper
• Neuroprotective Activities of Sertraline, Tiagabine, and Bicifadine with Autophagy-Inducing Potentials in a 6-Hydroxidopamine-Treated Parkinson’s Disease Cell Model

  2025cites this paper
• Metabolomic Signature in Men with Central Serous Chorioretinopathy Using UHPLC-MS.

  2025cites this paper
• Subchronic Treatment with CBZ Transiently Attenuates Its Anticonvulsant Activity in the Maximal Electroshock-Induced Seizure Test in Mice

  2024cites this paper
• Customized flexible platform - starting point for the development of wearable sensor for the direct electrochemical detection of kynurenic acid in biological samples.

  2024cites this paper
• The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy

  2024cites this paper
• The Oxidative Stress in Epilepsy—Focus on Melatonin

  2024influential citation
• New insights into healthy ageing, inflammageing and frailty using metabolomics

  2024cites this paper
• Chronic Treatment with Oxcarbazepine Attenuates Its Anticonvulsant Effect in the Maximal Electroshock Model in Mice

  2024cites this paper
• Role of non-receptor tyrosine kinases in epilepsy: significance and potential as therapeutic targets

  2024cites this paper
• The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy

  2024cites this paper
• Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials

  2024cites this paper
• Anti-Epileptic Indian Medicinal Plants: A Comprehensive Review on their Ethnopharmacological Perspectives of Recent Advancement

  2024cites this paper
• Kynurenic acid promotes osteogenesis via the Wnt/β-catenin signaling.

  2023cites this paper
•  Drug-Resistant Epilepsy; An Overview on Management and Treatment

  2023cites this paper
• Oxidative Stress and Neurodegeneration in Animal Models of Seizures and Epilepsy

  2023cites this paper
• Deletion of quinolinate phosphoribosyltransferase gene accelerates frailty phenotypes and neuromuscular decline with aging in a sex‐specific pattern

  2023cites this paper
• Caffeine and Its Interactions with Antiseizure Medications—Is There a Correlation between Preclinical and Clinical Data?

  2023cites this paper
• Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis

  2023cites this paper
• Second Generation of Antiepileptic Drugs and Oxidative Stress

  2023cites this paper
• Effect of caffeine on the anticonvulsant action of pregabalin against electroconvulsions in mice

  2022cites this paper
• Emerging therapeutic targets for epilepsy: preclinical insights

  2022cites this paper
• Effects of Antiarrhythmic Drugs on Antiepileptic Drug Action—A Critical Review of Experimental Findings

  2022influential citation
• Intravenous fosphenytoin as treatment for acute exacerbation of trigeminal neuralgia: A prospective systematic study of 15 patients

  2022cites this paper
• Selected Molecular Targets for Antiepileptogenesis

  2021influential citation
• How the Pregabalin (Lyrica) Administration as an Abuse Drug Can Affects the Reproductive Health of Male Wistar Rat

  2021cites this paper
• Influence of Topiramate on the Synaptic Endings of the Temporal Lobe Neocortex in an Experimental Model of Hyperthermia-Induced Seizures: An Ultrastructural Study

  2021cites this paper
• C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure Model

  2021cites this paper
• Amiodarone Enhances Anticonvulsive Effect of Oxcarbazepine and Pregabalin in the Mouse Maximal Electroshock Model

  2021influential citation
• The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies

  2021cites this paper
• Pharmakotherapie und intensivmedizinische Aspekte des Status epilepticus: Update 2020/2021

  2021cites this paper
• Exploring Quinazolinones as Anticonvulsants by Molecular Fragmentation Approach: Structural Optimization, Synthesis and Pharmacological Evaluation Studies

  2020cites this paper
• An investigation of pregabalin lactamization process and effect of various pH on reaction: A computational insight

  2020cites this paper
• Anti-Epileptogenic Effects of Antiepileptic Drugs

  2020cites this paper
• Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

  2020cites this paper
• Measuring Real-Time Medication Effects From Electroencephalography

  2020cites this paper
• Developing precision treatments for epilepsy using patient and animal models

  2020cites this paper
• Interactions of antiepileptic drugs with drugs approved for the treatment of indications other than epilepsy

  2020cites this paper
• Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain.

  2019cites this paper
• Effect of Pterostilbene, a Natural Analog of Resveratrol, on the Activity of some Antiepileptic Drugs in the Acute Seizure Tests in Mice

  2019cites this paper
• Tryptophan Metabolism: A Versatile Area Providing Multiple Targets for Pharmacological Intervention

  2019cites this paper
• Drug-drug interactions between antiepileptics and cannabinoids

  2019cites this paper
• Clinical opinion: Earlier employment of polytherapy in sequential pharmacotherapy of epilepsy.

  2019cites this paper
• Antiepileptic Drug Therapy in Patients with Drug-Resistant Epilepsy

  2019cites this paper
• Drugs for Neuropsychiatric Disorders

  2019cites this paper
• Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene

  2019cites this paper
• Amiodarone, a multi-channel blocker, enhances anticonvulsive effect of carbamazepine in the mouse maximal electroshock model.

  2018cites this paper
• A viewpoint on rational and irrational fixed-drug combinations

  2018cites this paper
• In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.

  2018cites this paper
• Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy

  2018influential citation
• Evaluation of the role of different neurotransmission systems in the anticonvulsant action of sildenafil in the 6 Hz-induced psychomotor seizure threshold test in mice.

  2018cites this paper
• Advances with extended and controlled release formulations of antiepileptics in the elderly

  2018cites this paper
• Evaluation of the combined treatment with pregabalin and inhibitors of the renin-angiotensin system against maximal electroshock in mice

  2018cites this paper
• Effects of tryptophan, kynurenine and kynurenic acid exerted on human reconstructed corneal epithelium in vitro

  2017cites this paper
• Effects of Pregabalin Drug on Level of Reproductive Hormones, Sexual Activity, Number and Weight of Offspring in Female Albino Rats

  2017cites this paper
• ANTICONVULSANT POTENCY OF 10 VARIOUS P-ISOPROPOXYPHENYLSUCCINIMIDE DERIVATIVES IN THE MAXIMAL ELECTROSHOCK-INDUCED SEIZURE THRESHOLD MODEL IN MICE

  2017cites this paper
• The presence of kynurenine aminotransferases in the human cornea: Evidence from bioinformatics analysis of gene expression and immunohistochemical staining

  2017cites this paper
• Maternal carbamazepine alters fetal neuroendocrine-cytokines axis.

  2017cites this paper
• Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy

  2017cites this paper
• Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents

  2017cites this paper
• Valproate and sodium butyrate attenuate manganese‐decreased locomotor activity and astrocytic glutamate transporters expression in mice

  2017cites this paper
• Gebelikte Antiepileptik İlaçların Kullanımının Değerlendirilmesi

  2016cites this paper
• Differential effects of lacosamide, phenytoin and topiramate on peripheral nerve excitability: An ex vivo electrophysiological study.

  2016cites this paper
• Protective action of nicotinic acid benzylamide in a variety of chemically-induced seizures in mice

  2016cites this paper
• Nonconvulsive status epilepticus in adults — insights into the invisible

  2016cites this paper
• Structural Exploration of Quinazolin‐4(3H)‐ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies

  2016cites this paper
• Pharmacogenetics of antiepileptic drugs: A brief review

  2016cites this paper
• Side Effects of Antiepileptic Drugs

  2016cites this paper
• Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids

  2016cites this paper
• Exploring the latest avenues for antiepileptic drug discovery and development

  2016influential citation
• Evidence for Efficacy of Combination of Antiepileptic Drugs in Treatment of Epilepsy

  2015cites this paper
• Outcomes associated with switching from monotherapy to adjunctive therapy for patients with partial onset seizures

  2015cites this paper
• Antiepileptic drugs and adverse skin reactions: An update

  2015cites this paper
• Effects of intracortical microinjection of vitamin B12 on penicillin-induced epileptiform activity in rats.

  2015cites this paper
• Alteration of pentylenetetrazole-induced seizure threshold by chronic administration of ginger (Zingiber officinale) extract in male mice

  2015influential citation
• The dilemma of treatments for epileptic patients with depression

  2015cites this paper
• Prospects of epileptogenesis prevention

  2015cites this paper
• Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus

  2015cites this paper
• The benefits of antiepileptic drug (AED) blood level monitoring to complement clinical management of people with epilepsy.

  2015cites this paper
• Assessment of combined treatment with vigabatrin and antihypertensive drugs against electroconvulsions in mice

  2015cites this paper
• Status Epilepticus : An Intractable Case with a Successful Outcome

  2015cites this paper
• PHARMACOKINETICS IN PSYCHIATRY AND NEUROLOGY

  2015cites this paper
• ω-Amidase: an underappreciated, but important enzyme in l-glutamine and l-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases

  2015cites this paper
• Sikkerhetsfarmakologiske studier av lamotrigin og valproat - mekanismestudier i nevronkulturer

  2014cites this paper
• Carbamazepine for prevention of chemotherapy-induced nausea and vomiting: a pilot study Carbamazepina para prevenção de náusea e vômito induzidos por quimioterapia: um estudo piloto

  2014cites this paper
• Carbamazepine for prevention of chemotherapy-induced nausea and vomiting: a pilot study

  2014cites this paper
• Effects of conventional anticonvulsant drugs on generalized tonic-clonic seizures in Noda epileptic rats.

  2014cites this paper
• Epilepsy-associated mutations in GABRG2: characterization and therapeutic opportunities

  2014cites this paper
• Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.

  2014cites this paper
• [Rational polytherapy of epilepsy in children].

  2014influential citation
• Safety considerations for patients with epilepsy taking antiepileptic drugs alongside caffeine or other methylxanthine derivatives

  2014cites this paper
• Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6Hz psychomotor seizure model - a type II isobolographic analysis.

  2014cites this paper
• The problem of osteoporosis in epileptic patients taking antiepileptic drugs

  2014cites this paper
• Old versus New: Why Do We Need New Antiepileptic Drugs?

  2014cites this paper
• Direct photodegradation of lamotrigine (an antiepileptic) in simulated sunlight--pH influenced rates and products.

  2014cites this paper
• Hippocampus, hippocampal sclerosis and epilepsy

  2013cites this paper
• Single centre 20 year survey of antiepileptic drug-induced hypersensitivity reactions

  2013cites this paper
• Modifications in the Seizures Susceptibility by Excitotoxic Neuronal Damage and Its Possible Relationship with the Pharmacoresistance

  2013cites this paper
• Glutamate-based anxiolytic ligands in clinical trials

  2013cites this paper
• Chapter 11 – Drugs for Neuropsychiatric Disorders

  2013cites this paper